Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-04-12 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于北京诺禾致源科技股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed opinion from CITIC Securities regarding the use of temporarily idle raised funds by Beijing Novogene Technology Co., Ltd. for cash management. It references regulatory guidelines, the amount and purpose of the raised funds, investment projects, risk control measures, internal decision procedures, and the sponsor's verification opinion. The document is not a full financial report but rather a regulatory compliance and verification statement related to the use of raised funds. It does not contain financial statements or earnings data. The document length is 3206 characters, which is relatively short and focused on a specific regulatory compliance matter. This fits best with the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-04-12 Chinese
北京诺禾致源科技股份有限公司关于召开2022年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2022 Annual General Meeting (AGM) of Beijing Novogene Technology Co., Ltd. It includes details such as the date, voting methods, meeting agenda items, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather the announcement and procedural information for the AGM. The document length is 3684 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-12 Chinese
北京诺禾致源科技股份有限公司关于作废部分已授予但尚未归属的限制性股票的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Beijing Nuohua Zhiyuan Technology Co., Ltd. regarding the cancellation of part of the granted but unvested restricted stocks under the company's 2021 restricted stock incentive plan. It details board and supervisory meetings, approvals, legal opinions, and the impact of the cancellation on the company and shareholders. The document is a formal announcement about a corporate action related to equity incentives, specifically the cancellation of restricted stock awards. It does not contain financial statements, earnings data, or detailed financial analysis. It is not a full annual or interim report, nor is it a call transcript or audit report. It is also not a proxy solicitation or voting results announcement. The content fits best under a Regulatory Filing (RNS) as it is a regulatory announcement about a corporate governance and equity incentive matter that does not fit other more specific categories.
2023-04-12 Chinese
北京诺禾致源科技股份有限公司第三届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Nuohe Zhiyuan Technology Co., Ltd. It discusses the approval of various proposals including the 2022 Annual Report, appointment of the 2023 audit firm, 2022 financial statements, profit distribution plan, related party transactions, supervisory board remuneration, supervisory board work report, special report on the use of raised funds, cancellation of restricted shares, cash management of idle raised funds, bank loan plans, asset impairment provisions, and the 2023 Q1 report. The document repeatedly states that these proposals will be submitted to the shareholders' meeting for approval and references detailed reports published separately on the Shanghai Stock Exchange website. The document itself does not contain the full annual report or financial statements but is a formal announcement of the Supervisory Board's meeting resolutions. The document length is 4362 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of supervisory board meeting resolutions and related corporate governance matters, not the full annual report or financial statements themselves.
2023-04-12 Chinese
北京诺禾致源科技股份有限公司2022年度审计报告及财务报表
Audit Report / Information Classification · 100% confidence The document is titled '审计报告及财务报表' which translates to 'Audit Report and Financial Statements' for the fiscal year 2022. It includes detailed audit opinions, key audit matters, and extensive financial statements such as consolidated balance sheets, income statements, cash flow statements, and notes to the financial statements. The presence of an auditor's report with audit opinions and detailed financial data confirms this is a standalone audit report rather than a full annual report or an announcement. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the document fits the category of Audit Report / Information (AR).
2023-04-12 Chinese
北京诺禾致源科技股份有限公司关于2022年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Beijing Nuohuzhiyuan Technology Co., Ltd. regarding the provision for asset impairment for the fiscal year 2022. It details the amounts of credit impairment losses and asset impairment losses, the accounting standards applied, and the impact on the company's financials. The document includes opinions from the audit committee, board of directors, independent directors, and supervisory board, confirming the appropriateness and compliance of the impairment provision. The document is relatively short (2029 characters) and focuses on a specific accounting adjustment rather than presenting a full financial report. It is not a full annual or interim report, nor is it a certification or a simple announcement of a report. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about accounting estimates and provisions that does not fit into other specific categories like Annual Report or Interim Report.
2023-04-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.